Key result
Selective deletion of Cd248 in Postn+ myofibroblasts does not reduce fibrosis or improve cardiac function in pressure-overload cardiomyopathy in mice.
Why the study?
CD248 has been implicated as a pro-fibrotic marker in ischemic cardiac injury, but its role in pressure-overload heart disease remained unclear.
Does selective deletion of Cd248 in Postn+ myofibroblasts attenuate pressure-overload induced cardiac remodeling and fibrosis in mice?
Does selective deletion of Cd248 in Postn+ myofibroblasts attenuate pressure-overload induced cardiac remodeling and fibrosis in mice?
CD248 deletion in Postn+ myofibroblasts does not attenuate fibrosis or improve function in pressure-overload cardiomyopathy, highlighting that its pro-fibrotic role is context-dependent.
Cd248 targeting in Postn+ myofibroblasts should not yet change practice for pressure-overload HF; challenges its context-independent pro-fibrotic role.
Cardiac fibrosis driven by activated myofibroblasts is a central feature of pressure-overload heart disease. CD248 (Endosialin/TEM1) has been implicated as a pro-fibrotic marker in ischemic cardiac injury, but its role in pressure overload remains unclear. Here, we tested whether selective deletion of Cd248 in Periostin-expressing ( Postn + ) myofibroblasts mitigates pressure-overload cardiomyopathy induced by transverse aortic constriction (TAC). We generated inducible PostnMCM +/− ;Cd248 fl/fl mice and validated tamoxifen-driven recombination specifically in Postn + interstitial cells. In vitro, Cd248 knockdown in primary adult mouse cardiac fibroblasts reduced TGF-β1–induced migration and the expression of actomyosin contractile markers; however, it notably failed to suppress the expression of key matrix genes ( Col1a1 , Postn ), indicating a molecular uncoupling of cytoskeletal dynamics from collagen synthesis. Consistent with this, Postn-restricted Cd248 deletion in vivo produced no significant differences in survival, echocardiographic indices, histological fibrosis, or cardiomyocyte hypertrophy compared to controls at 8 weeks post-TAC. Furthermore, while Cd248 + fibroblasts in the TAC model were enriched for chemotactic signaling programs, immune cell infiltration remained negligible, rendering this immunomodulatory function redundant. These data indicate that while CD248 regulates fibroblast cytoskeletal dynamics in vitro, it is dispensable for matrix production and fibrosis in vivo during pressure overload. Our results highlight the profound context-dependence of CD248 as an anti-fibrotic target. In pressure-overloaded mouse hearts, deleting Cd248 specifically in Postn + myofibroblasts fails to improve cardiac remodeling, despite clear cell-autonomous effects in mesenchymal cells in vitro. Single-cell analyses implicate CD248 in Postn + Cd248 + fibroblasts might affect cell chemotaxis and migration instead of ECM remodeling, highlighting the context-dependent efficacy of CD248-targeted antifibrotic strategies. • Specific deletion of Cd248 in Postn + myofibroblasts fails to attenuate fibrosis or improve function in pressure-overload cardiomyopathy. • Transcriptomic profiling reveals that CD248 regulates actomyosin contractility in vitro but is uncoupled from collagen matrix synthesis. • The pro-fibrotic function of CD248 is context-dependent, being critical for ischemic repair but dispensable for pressure-overload remodeling.
No takes yet. Share an insight, caveat, or question.
Li et al. (2026) studied this question. Selective deletion of Cd248 in Postn+ myofibroblasts does not reduce fibrosis or improve cardiac function in pressure-overload cardiomyopathy in mice.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: